Q1 2024 Holdings
Filed 2024-05-15 | 74 holdings | $1.8B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $75.7K | 3,012 | 0.0% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $248.4K | 10,000 | 0.0% |
| Nucana PLC | COMMON SHARES | GB00BYWYV | $340.0K | 1,307,875 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $374.3K | 8,733 | 0.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $384.3K | 6,173 | 0.0% |
| Inari Med Inc(NARIUSD) | COM | 45332Y109 | $490.2K | 10,216 | 0.0% |
| Perspective Therapeutics Inc | COM | 46489V104 | $511.8K | 430,105 | 0.0% |
| Ikena Oncology IncA | COM | 45175G108 | $543.3K | 382,616 | 0.0% |
| PDS Biotechnology Corp(PDSB) | COM | 70465T107 | $564.8K | 142,635 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX)Put | COM | 03237H101 | $852.0K | 300,000 | 0.0% |
| Immatics NV | *W EXP 07/01/2025 | N44445117 | $853.1K | 316,349 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $854.8K | 20,000 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $871.1K | 306,729 | 0.0% |
| Nucana PLC | SPONSORED ADR | 67022C106 | $884.2K | 3,400,739 | 0.0% |
| LivaNova PLC(LIVN) | SHS | G5509L101 | $1.1M | 20,456 | 0.1% |
| Inspire Med Sys Inc(INSP) | COM | 457730109 | $1.7M | 8,099 | 0.1% |
| Cooper Cos Inc(COO) | COM | 216648501 | $2.2M | 21,236 | 0.1% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $2.7M | 100,000 | 0.2% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $2.7M | 12,142 | 0.2% |
| Masimo Corp(MASI) | COM | 574795100 | $2.9M | 20,000 | 0.2% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $3.4M | 157,172 | 0.2% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $3.9M | 2,754,437 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $5.1M | 19,029 | 0.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $5.9M | 232,446 | 0.3% |
| Nextcure Inc | COM | 65343E108 | $6.0M | 2,671,856 | 0.3% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $6.3M | 198,186 | 0.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.5M | 150,775 | 0.4% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $6.9M | 1,518,230 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $7.2M | 141,162 | 0.4% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $7.3M | 429,746 | 0.4% |
| PepGen Inc(PEPG) | COM | 713317105 | $7.4M | 503,624 | 0.4% |
| Marinus Pharmaceuticals Inc(MRNS*)Call | COM | 56854Q200 | $7.7M | 854,700 | 0.4% |
| Marinus Pharmaceuticals Inc(MRNS*)Put | COM | 56854Q200 | $9.0M | 1,000,000 | 0.5% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $10.3M | 149,385 | 0.6% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $10.6M | 1,001,704 | 0.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $10.7M | 501,940 | 0.6% |
| Shockwave Med Inc(SWAVUSD) | COM | 82489T104 | $11.4M | 35,000 | 0.6% |
| Savara Inc(SVRA) | COM | 805111101 | $11.7M | 2,347,261 | 0.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $12.7M | 1,401,053 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $13.5M | 584,672 | 0.8% |
| Immunome Inc(IMNM) | COM | 45257U108 | $14.7M | 594,396 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $15.4M | 103,036 | 0.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $15.8M | 229,481 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.1M | 2,400,771 | 0.9% |
| Silk Rd Med Inc | COM | 82710M100 | $21.8M | 1,189,024 | 1.2% |
| Immatics NV(IMTX) | SHS | N44445109 | $22.7M | 2,163,646 | 1.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $24.2M | 353,851 | 1.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $29.5M | 227,488 | 1.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $30.2M | 1,984,962 | 1.7% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $30.3M | 1,696,752 | 1.7% |